Vaccines Medicines Approved in the EU (EMA)

Medicines the European Medicines Agency has recommended for use in the European Union on this topic.

Each number has its full source under its own list below.

Medicines authorised in the EU

68 medicines (authorised now). Newest first. Each links to its EMA page.

At the source
  • Aujemflu

    Active substance: A/(H1N1)-like virus antigen;A/(H3N2)-like virus antigen;B (Victoria lineage)-like virus antigen

    EMEA/H/C/006692
  • mCombriax

    Active substance: single-stranded, 5’-capped messenger RNAs (mRNAs) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding seasonal infl…

    EMEA/H/C/006472
  • Enflonsia

    Active substance: clesrovimab

    EMEA/H/C/006497
  • Supemtek

    Active substance: A/California/07/2009 (H1N1)pdm09-like strain (A/California/07/2009);A/Texas/50/2012 (H3N2)-like strain (A/Texas/50/2012);B/Brisbane/60/2008-like strain (B/Bris…

    EMEA/H/C/006674
  • mNexspike

    Active substance: single-stranded, 5’-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA template, encoding the N-terminal…

    EMEA/H/C/006428
  • VacPertagen

    Active substance: recombinant pertussis toxin;filamentous haemagglutinin

    EMEA/H/C/006304
  • Deqsiga

    Active substance: human normal immunoglobulin

    EMEA/H/C/006423
  • Capvaxive

    Active substance: pneumococcal polysaccharide serotype 3, 6A, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15B de-O-acetylated, 16F, 17F, 19A, 20A, 22F, 23A, 23B, 24F, 31, 33F and 35B conjuga…

    EMEA/H/C/006267
  • Vimkunya

    Active substance: Chikungunya virus (CHIKV) virus-like particle (VLP) proteins (capsid protein (C) and envelope proteins E1 and E2) derived from CHIKV Senegal strain 37997 produ…

    EMEA/H/C/005470
  • Kostaive

    Active substance: COVID-19 sa-mRNA Vaccine

    EMEA/H/C/006207
  • Flucelvax

    Active substance: A/Missouri/11/2025 (H1N1)pdm09-like strain (A/Tasmania/318/2025, CVR-351);A/Darwin/1415/2025 (H3N2)-like strain (A/Tasmania/787/2025, CVR-388);B/Pennsylvania/1…

    EMEA/H/C/006532
  • mResvia

    Active substance: Single-stranded 5' capped mRNA encoding the respiratory syncytial virus glycoprotein F stabilised in the prefusion conformation

    EMEA/H/C/006278
  • Ixchiq

    Active substance: Chikungunya virus, strain CHIKV LR2006-OPY1, live attenuated

    EMEA/H/C/005797
  • Fluenz

    Active substance: influenza virus (live attenuated);A/Missouri/11/2025 (H1N1)pdm09 - like strain (A/Switzerland/6849/2025, MEDI 400592);A/Darwin/1454/2025 (H3N2) - like strain (…

    EMEA/H/C/006514
  • Celldemic

    Active substance: Influenza virus A/turkey/Turkey/1/2005 (H5N1) NIBRG-23 strain, HA surface antigen

    EMEA/H/C/006052

Source: European Medicines Agency, Centrally authorised human medicines (EPAR), authorised now. Retrieved 12 Nov 2026.

Benchmarks on vaccines

Countries side by side on public measures for this topic.

All benchmarks

Acuitas market sizes and forecasts are only in our full reports. How we use public data.